Title: Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents
Subjects: Chemotherapy, Hypoglycemic agents, Diabetes, Cost-Benefit Analysis, Cost effectiveness, Drug therapy, Diabetes Mellitus, Therapeutic use, Hypoglycemic Agents